Q3 2020 Holdings
Filed 2020-11-16 | 75 holdings | $536.2M | 13F-HR/A | View on SEC ↗ · Holdings Table ↗
Amended (2020-11-17) | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Beigene LTD(ONC) | SPONSORED ADR | 07725L102 | $319.1M | 1,114,188 | 59.5% |
| Black Diamond Therapeutics I(BDTX) | COM | 09203E105 | $60.9M | 2,014,858 | 11.4% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $44.9M | 170,926 | 8.4% |
| Arcus Biosciences Inc(RCUS) | COM | 03969F109 | $35.7M | 2,084,883 | 6.7% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $19.0M | 250,000 | 3.5% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $17.0M | 1,566,361 | 3.2% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $15.3M | 370,000 | 2.8% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $14.8M | 1,000,000 | 2.8% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $7.1M | 300,000 | 1.3% |
| Immunomedics Inc(IMMU) | COM | 452907108 | $382.6K | 4,500,000 | 0.1% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $293.2K | 1,765,560 | 0.1% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $115.2K | 3,309,264 | 0.0% |
| Iteos Therapeutics Inc(5E7) | COM | 46565G104 | $107.2K | 4,345,016 | 0.0% |
| Springworks Therapeutics Inc | COM | 85205L107 | $99.0K | 2,075,905 | 0.0% |
| PMV Pharmaceuticals Inc(PMVP) | COM | 69353Y103 | $80.5K | 2,268,236 | 0.0% |
| Seattle Genetics Inc | COM | 812578102 | $78.3K | 400,000 | 0.0% |
| Odonate Therapeutics Inc | COM | 676079106 | $69.9K | 5,207,086 | 0.0% |
| Sage Therapeutics Inc(SG7) | COM | 78667J108 | $66.9K | 1,094,000 | 0.0% |
| Allakos Inc(ALLKGUSD) | COM | 01671P100 | $55.0K | 675,000 | 0.0% |
| Relay Therapeutics Inc(RLAY) | COM | 75943R102 | $53.3K | 1,251,959 | 0.0% |
| Intercept Pharmaceuticals in(ICPTUSD) | COM | 45845P108 | $48.8K | 1,176,000 | 0.0% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $47.3K | 1,354,392 | 0.0% |
| Compugen LTD(CGEN) | ORD | M25722105 | $38.7K | 2,383,673 | 0.0% |
| Esperion Therapeutics Inc NE(ESPR) | COM | 29664W105 | $36.2K | 975,000 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $33.8K | 2,287,782 | 0.0% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $33.5K | 1,466,051 | 0.0% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $32.8K | 2,325,000 | 0.0% |
| Kura Oncology Inc(KURA) | COM | 50127T109 | $32.2K | 1,050,289 | 0.0% |
| Gossamer BIO Inc(GOSS) | COM | 38341P102 | $31.8K | 2,562,358 | 0.0% |
| Avidity Biosciences Inc(RNA) | COM | 05370A108 | $31.6K | 1,121,327 | 0.0% |
| Marinus Pharmaceuticals Inc(MRNS*)A | COM NEW | 56854Q200 | $30.8K | 2,400,000 | 0.0% |
| Atreca Inc(BCELUSD) | CL A COM | 04965G109 | $30.8K | 2,202,333 | 0.0% |
| Amarin Corp PLC | SPONS ADR NEW | 023111206 | $29.5K | 7,000,000 | 0.0% |
| Cymabay Therapeutics Inc(CBAYUSD) | COM | 23257D103 | $29.0K | 4,000,000 | 0.0% |
| Uniqure NV(QURE) | SHS | N90064101 | $28.2K | 765,400 | 0.0% |
| Ideaya Biosciences Inc(IDYA) | COM | 45166A102 | $27.7K | 2,202,812 | 0.0% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $25.6K | 831,495 | 0.0% |
| Passage BIO Inc | COM | 702712100 | $25.3K | 1,928,315 | 0.0% |
| Kadmon Hldgs Inc(KDMN) | COM | 48283N106 | $24.3K | 6,205,882 | 0.0% |
| Pandion Therapeutics Inc(PAND) | COM | 698340106 | $24.2K | 2,107,513 | 0.0% |
| Therapeutics Acquisition COR | COM CL A | 88339T103 | $21.6K | 1,500,000 | 0.0% |
| Anaptysbio Inc(ANAB) | COM | 032724106 | $19.2K | 1,300,000 | 0.0% |
| Neoleukin Therapeutics Inc | COM | 64049K104 | $18.0K | 1,501,058 | 0.0% |
| Kodiak Sciences Inc(KOD) | COM | 50015M109 | $16.3K | 275,138 | 0.0% |
| Agenus Inc(AGENEUR) | COM NEW | 00847G705 | $16.0K | 4,000,000 | 0.0% |
| Direxion SHS ETF TR(LABDUSD) | DAILY S&P BIOTEC | 25460G716 | $14.9K | 250,000 | 0.0% |
| Global Blood Therapeutics in | COM | 37890U108 | $13.8K | 250,000 | 0.0% |
| Spectrum Pharmaceuticals Inc | COM | 84763A108 | $13.6K | 3,333,333 | 0.0% |
| DBV Technologies S A | SPONSORED ADR | 23306J101 | $13.0K | 7,534,598 | 0.0% |
| Milestone Pharmaceuticals in(MIST) | COM | 59935V107 | $13.0K | 1,777,194 | 0.0% |